Gleevec Buyers Say 1st Circ.’s Dismissal Misread Patent Law
s Dismissal Misread Patent Law. September 17, 2018 admin. Buyers of the leukemia drug Gleevec urged a First Circuit panel on Friday to rehear its …
In: PATENT NEWS
s Dismissal Misread Patent Law. September 17, 2018 admin. Buyers of the leukemia drug Gleevec urged a First Circuit panel on Friday to rehear its …
In: PATENT NEWS
Fed. Circ. Flips DuPont PTAB Loss, Axes Chemical Patent Law360 Full coverage
In: PATENT NEWS
Law360 (September 17, 2018, 6:18 PM EDT) — The Federal Circuit on Monday reversed a Patent Trial and Appeal Board ruling that DuPont didn’t …
In: PATENT NEWS
Gleevec Buyers Say 1st Circ.’s Dismissal Misread Patent Law Law360 Full coverage
In: PATENT NEWS
As for patent practice, the opinion articulates rules of patent law that conflict with long-established precedent, creating confusion about the principles of …
In: PATENT NEWS
Law360 (September 17, 2018, 5:49 PM EDT) — A California federal judge has ordered a nutritional supplement developer, its CEO and its attorney to …
In: PATENT NEWS
Experts Suggest Trade and Patent Changes Could Increase Healthcare Cost by $100 Billion Pharmaceutical Technology Magazine Full coverage
In: PATENT NEWS
SportStar tackled Wilson with the suit in May 2015, alleging a number of Wilson football helmet chin straps infringed its two patents and bringing …
In: PATENT NEWS
BuzzFeed Latest To Face Patent Suit By Cloud Company Law360 Full coverage
In: PATENT NEWS
“[BuzzFeed’s] acts of infringement caused damage to PersonalWeb, and PersonalWeb is entitled to recover from [BuzzFeed] the damages sustained.”
Designed by Industrial Action
Copyright © 2024 OPUS IP Limited. All Rights Reserved
OPUS IP Limited: COMPANY & OTHER LEGAL INFORMATION